Work

Advances in treatment of adenoid cystic carcinoma of the lacrimal gland

Year: 2025

Type: article

Abstract: Adenoid cystic carcinoma of the lacrimal gland (LGACC) is the most common type of malignant epithelial tumor of the lacrimal gland, which is characterized by a high recurrence rate, perineural invasion, and a propensity to metastasize to distant sites. Due to its unclear pathogenesis, LGACC has a poor prognosis and a high mortality rate. In recent years, a range of radiotherapy and chemotherapy have been clinically applied, leading to a shift in the treatment approach for LGACC. This article discussed the advances being made in the treatment of LGACC and provides readers with an overview of the impact of LGACC treatment modalities on patient survival and prognostic levels.

Source: International Journal of Ophthalmology

DOI: 10.18240/ijo.2025.08.20

Author: Jin-Bei Li

Institutions: Beijing Tongren Hospital, Capital Medical University

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,800